. Bioclinica Inc - EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement"), made as of this 19th day of September, 2008, is entered into by Bio-Imaging Technologies, Inc., a Delaware corporation with its principal place of business at 826 Newtown-Yardley Road, Newtown, Pennsylvania 18940 (the "Company"), and Peter Benton (the "Employee"). GENERAL SERVICES AGREEMENT . Subsidiary. BioClinica Optimizer is a product that allows biopharmaceutical companies to simulate and optimize their clinical supply chain. 26.04.2022. Key Highlights BioClinica Inc (BioClinica), formerly Bio-Imaging Technologies Inc, is a clinical trials services provider. BioClinica is a subsidiary of Clario. Certain information and footnote disclosures required under generally accepted accounting principles (GAAP) in . 290 Mysuru, IN Company Name Date Deal Size; References in this Quarterly Report on Form 10-Q to "BioClinica," "we," "us," or "our" refer to BioClinica, Inc., a Delaware corporation, and its subsidiaries, doing business as BioClinica. PURPOSE This General Services Agreement (this "Agreement") effective as of the last date of signature hereof (the "Effective Date"), by and between BioClinica, Inc., a Delaware Corporation, with its principal place of business at 826 Newtown-Yardley Road, Newtown, Pennsylvania, 18940-1721 ("BIOCLINICA") and Vascular . Tags. Basic Profile Business Address and Contact Details: BIOCLINICA, INC. AND SUBSIDIARIES Consolidated Statements of Income (in thousands, except per share data) (unaudited) For the Three Months Ended. It is inolved in Software publishing, consultancy and supply [Software . Bioclinica | 84,026 followers on LinkedIn. Clario is a technology company that generates the richest clinical evidence by fusing scientific expertise and global scale into the broadest endpoint . Type. Published: Jan 13, 2021 PRINCETON, N.J., Jan. 13, 2021 /PRNewswire/ -- Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced its partnership with IKCON PHARMA (subsidiary/affiliate of IKCON TECHNOLOGIES INC), a Clinical Research Organization (CRO) & technology services company. BioClinica offers its services to pharmaceutical, biotechnology, medical device companies and contract research organizations. Organization Name: Bioclinica Inc: IRS EIN (Taxpayer Id) 11-2872047: Bioclinica is a specialty clinical trial services provider that accelerates the development of new medical therapies. Before You Go Don't miss your chance for 50 free email contacts and prospecting data right inside of your inbox. Current assets: . CONSOLIDATED BALANCE SHEETS (unaudited) September 30, December 31, (in thousands) 2010 . It is classified as Subsidiary of Foreign Company and is registered at Registrar of Companies, Bangalore. 26.04.2022. The Central Index Key (CIK) for Bioclinica Inc is 822418. As part of the partnership, IKCON PHARMA will have access to Bioclinica's . IVR/IWR Interactive Response Solutions 2 TO AGREEMENT AND PLAN OF MERGER (this "Amendment") is made and entered into as of May 19, 2009 by and among Bio-Imaging Technologies, Inc., a Delaware corporation ("Parent"), BioClinica Acquisition, Inc., a Delaware corporation and direct wholly-owned Subsidiary of Parent ("Merger Sub"), and etrials Worldwide . 9/30/11. Bioclinica Inc 10-q - This Form 10 Q Quarterly Report Involves Bioclinica Inc. The Central Index Key (CIK) for Bioclinica Inc is 822418. 2009 . Item 1. newtown, pa.-- ( business wire )-- bioclinica®, inc. ( nas: bioc) , a leading global provider of clinical trial management solutions, and jll partners, inc., a leading private equity investment. Public. 26.04.2022. 27.04.2022. BioClinica is headquartered in Princeton, New Jersey, the US. Management of BioClinica, Inc. will host a conference call today at 11:00 a.m. EST. Bioclinica, Inc. and JLL Partners, Inc. announce the successful completion of the tender offer for all of the outstanding shares of Bioclinica's commo . Jan, 2021; Calls Received in the Last 12 Months (Drug Safety Solutions) 27 k: Clinical Trials Supported. 27.04.2022. Compare BioClinica to its competitors by revenue, employee growth and other metrics at Craft. Those who wish to participate in the conference call may telephone 877-869-3847 from the U.S.; international. PRINCETON, N.J., Jan. 13, 2021 /PRNewswire/ -- Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced its partnership with IKCON PHARMA (subsidiary/affiliate of IKCON TECHNOLOGIES INC), a Clinical Research Organization (CRO) & technology services company. BIOCLINICA, INC. AND SUBSIDIARIES. Pfizer and BioNTech Submit Application for U.S. Bioclinica Inc is incorporated in Delaware and the fiscal year end is in 31 December. Bioclinica Inc 10-Q for BIOCLINICA INC - Sample agreements, legal documents, and contracts from RealDealDocs. -IKCON PHARMA INC a subsidiary/affiliate of IKCON TECHNOLOGIES INC is a clinical research, digital technology solutions and services provider supporting the life science industry has announced its partnership with Bioclinica, a world-leading provider of clinical science and technology expertise supporting the life science . Bionical Emas stands with Ukraine. 100,000. The company's core products and services include medical imaging analysis and consultation, cardiovascular safety and efficacy, patient recruitment and retention, central lab services and e-health technologies thus enhancing the overall efficiency and productivity of clinical trials. / Bioclinica, Inc. Bioclinica, Inc. Website. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. BIOCLINICA and VASCULAR BIOGENICS are individually referred to as a "Party" and collectively as the "Parties". 23 Branches. But the most successful trials require the ability to see key details and uncover hidden insights. BioClinica Office Locations BioClinica has offices in Princeton, San Mateo, Shanghai, München and in 3 other locations Open Map View Princeton, NJ, US (HQ) 211 Carnegie Center Dr San Mateo, CA, US 777 Mariners Island Blvd # 550 Shanghai, CN 11F No.3, Lane 227, Dong Yu Road, Pudong New Area München, DE Landsberger Str. The . Our approach. ASSETS References in this Quarterly Report on Form 10-Q to "BioClinica," "we," "us," or "our" refer to BioClinica, Inc., a Delaware corporation, and its subsidiaries, doing business as BioClinica. Type. View All with Free Trial. Financial Statements. Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details. 500,000 and its paid up capital is Rs. 26.04.2022. Bioclinica is now Clario. 200: BioClinica Acquisitions / Subsidiaries. BioClinica is headquartered in Princeton, New Jersey, the US. Financial Statements. Certain information and footnote disclosures required under generally accepted accounting principles (GAAP) in . BioClinica offers its services to pharmaceutical, biotechnology, medical device companies and contract research organizations. While there are many companies available to support trials, many offer a monolithic approach—one that is massive, indivisible, and rigid. The Company, throughits subsidiaries, provides medical imaging, patient management, cardiac, payment, cloud hosting, and clinical. CCBR-SYNARC and BioClinica, two US-based providers of specialised clinical-trial services, are merging their capabilities in medical imaging, patient recruitment, drug-development technology/consulting, cardiac safety and central-laboratory analysis. 9/30/12. BioClinica offers Optimizer both through software licensing and as an outsourced service to make these benefits accessible to organizations of any size. BioClinica, Inc. is a leading global provider of integrated, technology-enhanced clinical trial management services. It is classified as a private subsidiary of a foreign copmany and is located in Mysore, Karnataka. Relief Therapeutics' Wholly Owned Subsidiary, Apr Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Pku Golike. These methods tend to focus on the system and . Exhibit 10.10 . Bioclinica is a specialty clinical trial services provider that accelerates the development of new medical therapies.Clinical trials are a complex undertaking. THIS AMENDMENT NO. The report contains detailed information about BioClinica, Inc. that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history. BioClinica supports pharmaceutical and medical device innovation with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management and clinical supply chain design and optimization solutions. OVERVIEW - BIOCLINICA INDIA PRIVATE LIMITED. 2009 . Bioclinica Inc is incorporated in Delaware and the fiscal year end is in 31 December. Menu; Plans & Pricing; About; Contact; . ASSETS . Our expert teams work seamlessly across our divisions, where they continuously use their experience and knowledge to plan, develop and execute projects to exceptionally . Subsidiary. Company Description: BioClinica helps drug developers keep track of their X-rays, MRIs, and other forms of medical imaging collected during clinical drug and medical device trials. Bioclinica Inc 10-K filing includes an Exhibit 21 subsidiary information. Subsidiary. BioClinica Holding I, LP operates as a holding company. At Clario we are simplifying the clinical trial process for sponsors, sites, and CROs. -IKCON PHARMA INC a subsidiary/affiliate of IKCON TECHNOLOGIES INC is a clinical research, digital technology solutions and services provider supporting the life science industry has announced its partnership with Bioclinica, a world-leading provider of clinical science and technology expertise supporting the life science . We provide a unique, combined approach to Clinical Development, Early Access Programs and Clinical Trial Supply. Jan 13, 2021, 09:30 ET PRINCETON, N.J., Jan. 13, 2021 /PRNewswire/ -- Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced its partnership. It provides . Bioclinica Inc 10-K filing includes an Exhibit 21 subsidiary information. Our expertise. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age. Get a D&B Hoovers Free Trial. CONSOLIDATED BALANCE SHEETS (unaudited) September 30, December 31, (in thousands) 2010 . It's authorized share capital is INR 5.00 lac and the total paid-up capital is INR 1.00 lac. Bioclinica India Private Limited is an unlisted private company incorporated on 08 December, 2008. Bioclinica India Private Limited is a Private incorporated on 08 December 2008. Tags. BioClinica's main competitors include Calyx, Synexus, Veeva Systems and Cerner. Corporation Parent. For the Nine Months Ended. newtown, pa.-- ( business wire )--bioclinica®, inc. (nasdaq: bioc), a leading global provider of clinical trial management solutions, and jll partners, inc., a leading private equity investment. Basic Profile. Creating Clarity in Clinical Trials Clinical trials are complex and monolithic approaches are the norm. No financial terms were disclosed for the merger, which . Our platform integrates the broadest endpoint technologies, fused with deep scientific expertise and global scale. Scope Road, Newtown, Pennsylvania, 18940-1721 ("BIOCLINICA") and Vascular Biogenics Ltd. with its principal place of business at 6 Jonathan Netanyahu Street, Or Yehuda, Israel 60376 ("VASCULAR BIOGENICS"). BioClinica Inc - Company Profile & SWOT Analysis, is a source of comprehensive company data and information. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age. Menu; Plans & Pricing; About; . Highlights BioClinica Inc (BioClinica), formerly Bio-Imaging Technologies Inc, is a clinical trials services provider. BioClinica Operating Metrics. Further information can be found in the risk factors contained in the Annual Report of BioClinica, Inc. on Form 10-K for the year ended December 31, 2011 and most recent filings. 4 k: Long-term Clients (Drug Safety Solutions) 35: Therapies Approved. Item 1. 21 Subsidiaries. 21st January 2014. by. See jobs Follow View all 2,871 employees Overview Jobs Life About us ERT, the global. BioClinica Inc Key Recent Developments Its subsidiary Tevano Systems Inc. is the developer of Health Shield™, an AI-driven, electronic tablet that video displays a user with their body temperature and other information. SOUTH PLAINFIELD, NJ. Contact Information Website www.bioclinica.com Formerly Known As . The company has presence in North America, Latin America, Europe, and Asia. Bioclinica Pharmaceutical Manufacturing Princeton, New Jersey 83,932 followers Bioclinica is now Clario. Its authorized share capital is Rs. Public. SOUTH PLAINFIELD, NJ. BioClinica Agreement #40801 . Type. Type. Relief Therapeutics' Wholly Owned Subsidiary, Apr Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Pku Golike. Peter Mansell. Our uniquely engineered and validated clinical trail management software, connected devices and artificial intelligence solutions across Cardiac Safety, eCOA, Medical Imaging, Precision Motion and Respiratory provide the broadest evidence generation platform in the industry. Technology clinical research enterprise software medical imaging medtech. The company has presence in North America, Latin America, Europe, and Asia. The firm provides medical imaging support services including image processing and analysis, digitizing, archival services, and database maintenance. Delivering Trial Anywhere™ with reliability and precision BIOCLINICA, INC. AND SUBSIDIARIES. a wholly-owned subsidiary of BioCore . View All with Free Trial. Pfizer and BioNTech Submit Application for U.S. With 24/7 partner and patient support, along with training and instructions integrated into our devices, our technology and clinical trial . It is one of the corporates which submit 10-K filings with the SEC. | ERT, the global clinical endpoint technology leader, and Bioclinica, a technological and scientific leader in medical imaging, is now the combined company of Clario.